AI assistant
Sending…
CorMedix Inc. — Director's Dealing 2010
Mar 24, 2010
32333_dirs_2010-03-24_6d3873f5-00c3-43fc-a331-723f1daf6e8c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: CorMedix Inc. (CRMD)
CIK: 0001410098
Period of Report: 2010-03-24
Reporting Person: Pfaffle Antony (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, $0.001 par value per share | 2475 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-Voting Subordinated Class A Common Stock | $ | Common Stock, $0.001 par value per share (12375) | Direct |
Footnotes
F1: All shares of Non-Voting Common Stock will be automatically converted into shares of common stock at a conversion ratio of one share of common stock for 7.836
shares of Non-Voting Common Stock (was a one-for-one ratio prior to the 1 for 7.836 reverse stock split effected February 24, 2010) upon the closing of the
Company's initial public offering.
More from CorMedix Inc.
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Annual Report
2026
Apr 29
Regulatory Filings
2026
Apr 27
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Jan 27
Director's Dealing
2026
Jan 27